Calcd for C25H18ClN3O3S: C, 63.09; H, 3.81; N, 8.83; S, 6.74. leukemic cells continues to be related to activation from the STAT3 pathway [8C11]. Therefore, significant effort continues to be committed to the development of medications that focus on STAT3 activators, and contains Eriodictyol gefitinib (EGFR inhibitor) [12], dasatinib (Src inhibitor) [13] and tocilizumab (IL-6 … Continue reading Calcd for C25H18ClN3O3S: C, 63